Dingemans starts a new chapter

In the first of a series of monthly corporate Q&As, GlaxoSmithKline’s chief financial officer tells Financial News there is life after Goldman Sachs

In the first of a series of monthly corporate Q&As, GlaxoSmithKline’s chief financial officer tells Financial News there is life after Goldman Sachs.

Financial News: What are the short-term priorities for GlaxoSmithKline?

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump